- Home
- About Us
- Divisions
- Adolescent and Young Adult Medicine
- Allergy and Immunology
- Blood and Marrow Transplantation and Cellular Therapies
- Cardiology
- Child Advocacy
- Emergency Medicine
- Endocrinology
- Gastroenterology, Hepatology and Nutrition
- General Academic Pediatrics
- Genetic and Genomic Medicine
- Health Informatics
- Hematology-Oncology
- Infectious Diseases
- Nephrology
- Neurology and Child Development
- Newborn Medicine
- Paul C. Gaffney Division of Pediatric Hospital Medicine
- Pulmonology
- Rheumatology
- Centers & Institutes
- Center for Pediatric Research in Obesity and Metabolism
- Center for Rare Disease Therapy
- Children's Neuroscience Institute
- Cystic Fibrosis Research Center
- Institute for Infection, Inflammation, and Immunity in Children
- Pediatric Asthma Center
- Pediatric Institute for Heart Regeneration and Therapeutics
- Richard King Mellon Foundation Institute for Pediatric Research
- Pittsburgh Vaccine Trials Unit
- The Pittsburgh Study
- Research
- Diversity
- Education
- Faculty Affairs
- News
- People
- Podcasts
Celedón Lab
Decoding the Enigmatic Causes of Asthma
The most common serious chronic disease in infants and children, asthma is caused by many factors, including genetics and ethnicity, environment, diet, stress and more. Today, researchers are in the early stages of understanding these causes, and their precise relationship to pediatric asthma. Pulmonologist and genetic epidemiologist Juan C. Celedón, MD, DrPH, and his team have taken a leadership role in the identification of genetic factors and environmental exposures that influence the development of asthma and chronic obstructive pulmonary disease (COPD), particularly in ethnic minorities.
Dr. Celedón’s team first identified MMP12 and TSLP as susceptibility genes for asthma- or COPD-phenotypes in humans, while also showing that racial ancestry partly explains marked differences in the burden of asthma and COPD between Puerto Ricans and Mexicans – the Hispanic paradox. Moreover, Dr. Celedón’s group first reported that genetic and epigenetic variation in a susceptibility gene for post-traumatic stress disorder (ADCYAP1R1) is associated with asthma, and that exposure to violence is associated with both ADCYAP1R1methylation and asthma. They then showed that both psychosocial stress and a genetic variant in ADCYAP1R1 are associated with reduced response to short-acting bronchodilators in children with or at risk for asthma. Based on that work, Dr. Celedón’s team is now examining whether changes in DNA methylation and gene expression induced by violence or stress lead to asthma or reduced response to treatment for asthma in minority children.
Dr. Celedón’s research team also first showed that low vitamin D levels are associated with severe asthma attacks in school-aged children. They are now conducting a National Institutes of Health-funded clinical trial of vitamin D to prevent severe asthma attacks in childhood.
Affiliated Faculty and Staff
- Juan C. Celedón, MD, DrPH - Principal Investigator
- Erick Forno, MD, MPH, ATSF
- Franziska J. Rosser, MD, MPH
- Wei Chen, PhD
- Yueh-Ying Han, PhD
- Nadia Boutaoui, PhD
Areas of Focus and Clinical Studies
The research of the Celedón Lab combines population-based investigations plus basic laboratory research. Members of the team are currently focused on three subject areas.
Opportunities to Join
The Celedón Lab is looking for talented post-doctoral fellows and graduate students.
Published Articles
View a list of recently published articles.